Drug Testing Locations - Fountain Hill, PA

Drug Testing in Fountain Hill, PA

Fountain Hill, Pennsylvania Statistics

In 2022, there were 47 drug overdose deaths in Fountain Hill, located in Lehigh County.

Lehigh County reported a 15% increase in drug-related arrests in 2021.

Fountain Hill recorded 25 cases of opioid overdoses in 2021, as per Lehigh County reports.

In 2020, Lehigh County had approximately 600 admissions to drug treatment facilities.

Fountain Hill saw a 10% increase in Narcan administrations in 2021.

Lehigh County's drug-induced death rate was 18 per 100,000 population in 2020.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Fountain Hill, PA & Drug Testing Policies

Employers in Fountain Hill, PA, are increasingly implementing stringent drug testing policies to ensure a safe workplace. Pre-employment screenings are common and are often accompanied by random testing for employees. The goal is to reduce on-the-job accidents and enhance productivity.

In accordance with the Pennsylvania state guidelines, many local companies are leveraging resources from the Department of Labor and Industry to implement effective drug-free workplace programs. Emphasis is placed on employee education about substance abuse and its impact on health and occupational safety.

Government Efforts with Drug Problems in Fountain Hill, PA

The government in Fountain Hill, PA, is actively working to combat the drug problem within the community. Efforts include enhanced funding for opioid prevention programs. Additionally, they have established partnerships with local law enforcement to improve the response to drug-related incidents.

Statewide initiatives, such as the Pennsylvania Department of Drug and Alcohol Programs, are also supporting efforts in Fountain Hill by offering grants to support local rehabilitation centers. You can find more information on their website. The collaborative approach aims to reduce drug supply and demand within Lehigh County.

Local Drug Busts & News in Fountain Hill, PA

Recently, Fountain Hill, PA, has been the site of several significant drug busts, highlighting the ongoing challenges law enforcement faces. In a notable case from 2022, authorities seized a substantial amount of heroin and methamphetamine in a multi-agency operation, demonstrating the collaborative efforts of local and state law enforcement agencies.

Community engagement events have also been organized to increase awareness and prevent drug abuse. For instance, Fountain Hill community centers are hosting educational sessions aimed at youth and their parents, providing valuable resources and information on the consequences of drug use.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Fountain Hill, PA. Trusted by employers nationwide for accurate results and exceptional service.

Pennsylvania DOT/Non DOT Physicals

Pennsylvania Vision Tests

Pennsylvania Audiograms

Pennsylvania Respirator Fit Tests

Pennsylvania Lift Tests

Pennsylvania Background Checks

Clinical Testing Services

TB Testing in PA

Diabetes Testing in PA

Infectious Disease Testing in PA

Sickle Cell Anemia Testing in PA

Women/Men's Health Testing in PA

Resources & Citations

Caron Treatment Centers

PA Dept. of Drug & Alcohol Programs

Livengrin Foundation

Lehigh Valley Health Network

Bethlehem Health Bureau

Gateway Rehab

Nar-Anon Family Groups

Valley Youth House

Drug Testing Near Fountain Hill, PA

Dorneyville, PA

Hokendauqua, PA

Coopersburg, PA

Catasauqua, PA

North Catasauqua, PA

Allentown, PA

Fullerton, PA

DeSales University, PA

Hellertown, PA

Freemansburg, PA

Northampton, PA

Bethlehem, PA

Salisbury, PA

Frequently Asked Questions

Customer Reviews